Supplemental Materials for JAAD Publication JAAD-D-22-02295, A Randomized, Double-Blind, Placebo-Controlled Phase II Study to Evaluate the Efficacy and Safety of Ivarmacitinib (SHR0302) in Adult Patients with Moderate to Severe Alopecia Areata
收藏NIAID Data Ecosystem2026-05-01 收录
官方服务：
资源简介：
These are supplemental data sets to the JAAD publication entitled "A Randomized, Double-Blind, Placebo-Controlled Phase II Study to Evaluate the Efficacy and Safety of Ivarmacitinib (SHR0302) in Adult Patients with Moderate to Severe Alopecia Areata".
创建时间：
2023-03-29
